Viewing Study NCT00739635


Ignite Creation Date: 2025-12-24 @ 10:13 PM
Ignite Modification Date: 2025-12-25 @ 7:48 PM
Study NCT ID: NCT00739635
Status: COMPLETED
Last Update Posted: 2016-02-04
First Post: 2008-08-21
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Efficacy, Safety and Tolerability of Neramexane in Patients With Subjective Tinnitus
Sponsor: Merz Pharmaceuticals GmbH
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module